ChromaDex Corp. (Irvine, CA) raised $4.2 million through a private placement stock offering that began in March, the company said on August 8. New Castle Financial Services (New York City) acted as the private placement agent for the transaction, which yielded gross proceeds of $4.67 million.
ChromaDex Corp. (Irvine, CA) raised $4.2 million through a private placement stock offering that began in March, the company said on August 8.
New Castle Financial Services (New York City) acted as the private placement agent for the transaction, which yielded gross proceeds of $4.67 million.
“Subsequent to our recent emergence as a publicly traded company through completion of a reverse merger, today we are pleased to announce the closing of this private placement to provide ChromaDex with additional working capital to support our business expansion plans,” said ChromaDex cofounder and CEO Frank Jaksch. “We are pleased with the amount raised and confident this financing will help position ChromaDex to support the next phase of our growth in our quest to become the premier provider of phytochemical and botanical reference standards to the functional food, cosmetic, dietary supplement, pharmaceutical, life sciences, and other industries.”
The Nutritional Outlook Podcast Episode 33: Keeping up with contract manufacturing
July 26th 2024Nutritional Outlook talks to Lauren Samot, commercial innovation leader, and Blayney McEneaney, sales executive at Vitaquest International, about trends within the contract manufacturing space, and the ways in which contract manufacturers like Vitaquest keep up with the market and differentiate themselves from the competition.